Evidence map›Paper›PMID 42088103›Full record

ArticleIJU case reports2026

Metastasis of Hepatocellular Carcinoma to the Urinary Bladder: A Case Report and Literature Review.

Eri Fukagawa, Suguru Oka, Kazushige Sakaguchi, Shigeki Yamamoto, Masako Ikemura, Norio Akuta, Shinji Urakami

Abstract read
In one paragraph

Article in IJU case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eri FukagawaDepartment of Urology Toranomon Hospital Tokyo Japan.ORCID https://orcid.org/0000-0002-7182-7764
Suguru OkaDepartment of Urology Toranomon Hospital Tokyo Japan.
Kazushige SakaguchiDepartment of Urology Toranomon Hospital Tokyo Japan.
Shigeki YamamotoDepartment of Hepatology Toranomon Hospital Tokyo Japan.
Masako IkemuraDepartment of Pathology Toranomon Hospital Tokyo Japan.
Norio AkutaDepartment of Hepatology Toranomon Hospital Tokyo Japan.
Shinji UrakamiDepartment of Urology Toranomon Hospital Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Although secondary bladder tumors from distant metastases are rare, those originating from hepatocellular carcinoma are particularly uncommon, with only a few cases reported to date. Case Presentation: An 81 year old male with hepatocellular carcinoma developed a rapidly growing 23 mm-sized bladder tumor during systemic therapy with atezolizumab and bevacizumab. Cystoscopy revealed a pedunculated, nonpapillary tumor on the posterior wall of the bladder, and transurethral resection was urgently performed due to bleeding. Histopathology and immunohistochemistry confirmed bladder metastasis of hepatocellular carcinoma. Conclusion: Although rare, rapidly enlarging bladder tumors in patients with hepatocellular carcinoma should be considered as possible metastatic lesions in the differential diagnosis.

Indexed as

hepatocellular carcinomaneoplasm metastasistransurethral resection of bladderurinary bladderurinary bladder neoplasms

Identifiers

PMID42088103
PMCPMC13136500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.